Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging.
- 1 August 1991
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 157 (2) , 347-351
- https://doi.org/10.2214/ajr.157.2.1853820
Abstract
Decisions regarding the surgical approach in osteosarcoma require accurate assessment of tumor extent. In order to determine whether enhancement with gadopentetate dimeglumine could add clinically significant information to that available with unenhanced MR imaging, 21 patients with osteosarcoma underwent preoperative MR imaging. T1- and T2-weighted spin-echo MR images obtained before and after administration of IV gadopentetate dimeglumine were evaluated to determine the conspicuity of marrow and soft-tissue extent of tumor, including tumor involvement of major neurovascular bundles and adjacent joints. MR results were correlated with tumor margins found at surgery. In some instances, use of gadopentetate dimeglumine obscured differentiation of tumor from normal marrow or tumor infiltration into perineurovascular fat, and tumor extension through pseudocapsule could not be differentiated from peritumoral edema after contrast administration. Contrast enhancement did assist in differentiation of intraarticu...Keywords
This publication has 0 references indexed in Scilit: